US Stock MarketDetailed Quotes
CUE Cue Biopharma
- 1.080
- -0.010-0.92%
Trading Nov 21 13:20 ET
68.42MMarket Cap-1186P/E (TTM)
1.095High1.020Low222.95KVolume1.090Open1.090Pre Close235.96KTurnover0.36%Turnover RatioLossP/E (Static)63.35MShares3.24952wk High2.70P/B67.88MFloat Cap0.45052wk Low--Dividend TTM62.86MShs Float31.690Historical High--Div YieldTTM6.88%Amplitude0.450Historical Low1.058Avg Price1Lot Size
Cue Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -40.72%32.42M | -48.13%30.03M | -38.02%41.03M | -36.41%48.51M | -36.41%48.51M | -7.59%54.69M | -12.46%57.89M | -2.54%66.2M | 18.51%76.29M | 18.51%76.29M |
| -Cash and cash equivalents | -40.72%32.42M | -43.24%30.03M | -27.15%41.03M | -6.01%48.51M | -6.01%48.51M | 83.98%54.69M | -20.00%52.9M | -17.09%56.32M | -19.82%51.61M | -19.82%51.61M |
| -Short-term investments | ---- | ---- | ---- | --0 | --0 | --0 | --4.99M | --9.88M | --24.68M | --24.68M |
| Receivables | 89.77%3.15M | 62.73%1.85M | 614.29%1.4M | 2,878.95%1.7M | 2,878.95%1.7M | 108.67%1.66M | 54.21%1.14M | -96.76%196K | -98.19%57K | -98.19%57K |
| -Accounts receivable | 89.77%3.15M | 62.73%1.85M | 614.29%1.4M | 2,878.95%1.7M | 2,878.95%1.7M | 108.67%1.66M | 54.21%1.14M | -78.81%196K | -98.19%57K | -98.19%57K |
| Other current assets | 44.55%1.68M | 5.91%2.02M | -5.08%2.24M | 47.68%1.24M | 47.68%1.24M | -32.31%1.17M | -10.78%1.91M | 19.92%2.36M | -11.92%841K | -11.92%841K |
| Total current assets | -35.23%37.26M | -44.37%33.9M | -35.03%44.67M | -33.34%51.45M | -33.34%51.45M | -6.78%57.52M | -11.69%60.94M | -9.47%68.76M | 12.73%77.19M | 12.73%77.19M |
| Non current assets | ||||||||||
| Net PPE | -43.34%4.6M | -39.00%5.48M | -35.60%6.33M | -33.49%7.12M | -33.49%7.12M | -27.47%8.13M | -23.02%8.98M | -16.75%9.83M | -10.23%10.7M | -10.23%10.7M |
| -Gross PPE | -33.35%8.5M | -31.19%9.28M | -29.30%10.04M | -28.17%10.73M | -28.17%10.73M | -16.37%12.76M | -13.17%13.49M | -8.19%14.2M | -2.74%14.94M | -2.74%14.94M |
| -Accumulated depreciation | 15.86%-3.9M | 15.62%-3.8M | 15.16%-3.71M | 14.76%-3.62M | 14.76%-3.62M | -14.33%-4.64M | -16.52%-4.51M | -19.38%-4.37M | -23.18%-4.24M | -23.18%-4.24M |
| Non current prepaid assets | -9.64%2.69M | -9.64%2.69M | -9.64%2.69M | -13.67%2.69M | -13.67%2.69M | -4.46%2.98M | -21.60%2.98M | 11.58%2.98M | 14.52%3.12M | 14.52%3.12M |
| Other non current assets | -3.70%260K | -4.03%262K | 112.00%265K | -3.60%268K | -3.60%268K | -3.91%270K | -3.87%273K | -56.45%125K | -4.14%278K | -4.14%278K |
| Total non current assets | -33.57%7.55M | -31.07%8.43M | -28.20%9.28M | -28.52%10.08M | -28.52%10.08M | -22.11%11.37M | -22.33%12.23M | -12.40%12.93M | -5.60%14.1M | -5.60%14.1M |
| Total assets | -34.95%44.81M | -42.14%42.33M | -33.95%53.95M | -32.59%61.53M | -32.59%61.53M | -9.71%68.89M | -13.67%73.16M | -9.95%81.68M | 9.45%91.28M | 9.45%91.28M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 161.05%6.47M | 65.79%3.91M | 82.19%3.92M | 28.19%3.5M | 28.19%3.5M | 21.27%2.48M | 50.26%2.36M | -17.81%2.15M | 5.42%2.73M | 5.42%2.73M |
| -accounts payable | 161.05%6.47M | 65.79%3.91M | 82.19%3.92M | 28.19%3.5M | 28.19%3.5M | 21.27%2.48M | 50.26%2.36M | -17.81%2.15M | 5.42%2.73M | 5.42%2.73M |
| Current accrued expenses | -53.19%2.4M | -23.14%3.13M | -26.06%2.1M | 49.73%1.92M | 49.73%1.92M | 32.17%5.13M | 14.53%4.08M | -16.53%2.84M | -50.99%1.28M | -50.99%1.28M |
| Current debt and capital lease obligation | -6.85%6.86M | -4.27%7.02M | 13.95%7.17M | 39.29%7.33M | 39.29%7.33M | 71.29%7.36M | 129.29%7.33M | 16.83%6.3M | 6.72%5.26M | 6.72%5.26M |
| -Current debt | 0.00%3.96M | 0.00%3.96M | 33.75%3.96M | 101.88%3.96M | 101.88%3.96M | 311.53%3.96M | --3.96M | --2.96M | --1.96M | --1.96M |
| -Current capital lease obligation | -14.83%2.9M | -9.30%3.05M | -3.66%3.21M | 2.06%3.37M | 2.06%3.37M | 1.92%3.4M | 5.29%3.37M | -38.16%3.33M | -33.09%3.3M | -33.09%3.3M |
| Current deferred liabilities | -88.43%259K | -61.68%976K | -29.00%1.79M | --2.11M | --2.11M | --2.24M | --2.55M | --2.52M | --0 | --0 |
| Other current liabilities | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current liabilities | -2.42%16.79M | 0.93%16.46M | 30.99%18.09M | 47.91%17.08M | 47.91%17.08M | 68.33%17.21M | 95.93%16.31M | 21.02%13.81M | -9.69%11.55M | -9.69%11.55M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -70.56%2.65M | -60.36%4.25M | -53.08%5.82M | -47.60%7.36M | -47.60%7.36M | -41.13%9.02M | -35.72%10.72M | -15.12%12.41M | 174.41%14.05M | 174.41%14.05M |
| -Long term debt | -74.26%1.33M | -62.63%2.29M | -54.16%3.24M | -47.70%4.2M | -47.70%4.2M | -42.62%5.16M | -38.28%6.12M | -28.23%7.08M | --8.04M | --8.04M |
| -Long term capital lease obligation | -65.60%1.33M | -57.33%1.96M | -51.64%2.58M | -47.46%3.16M | -47.46%3.16M | -39.01%3.86M | -31.95%4.6M | 12.06%5.33M | 17.51%6.02M | 17.51%6.02M |
| Non current deferred liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --136K | --445K | ---- | ---- |
| Total non current liabilities | -70.56%2.65M | -60.86%4.25M | -54.70%5.82M | -47.60%7.36M | -47.60%7.36M | -41.13%9.02M | -34.90%10.85M | -12.07%12.86M | 174.41%14.05M | 174.41%14.05M |
| Total liabilities | -25.85%19.44M | -23.76%20.71M | -10.32%23.91M | -4.52%24.45M | -4.52%24.45M | 2.69%26.22M | 8.67%27.16M | 2.44%26.67M | 42.95%25.6M | 42.95%25.6M |
| Shareholders'equity | ||||||||||
| Share capital | 33.33%60K | 9.09%48K | 11.63%48K | 9.30%47K | 9.30%47K | 28.57%45K | 25.71%44K | 26.47%43K | 33.53%43K | 33.53%43K |
| -common stock | 33.33%60K | 9.09%48K | 11.63%48K | 9.30%47K | 9.30%47K | 28.57%45K | 25.71%44K | 26.47%43K | 33.53%43K | 33.53%43K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -15.50%-332.37M | -16.97%-323.71M | -18.96%-313.54M | -20.26%-301.19M | -20.26%-301.19M | -22.00%-287.76M | -23.05%-276.75M | -24.50%-263.57M | -26.85%-250.46M | -26.85%-250.46M |
| Paid-in capital | 8.26%357.67M | 6.99%345.28M | 7.83%343.53M | 6.97%338.23M | 6.97%338.23M | 15.24%330.38M | 13.38%322.72M | 15.28%318.58M | 20.27%316.19M | 20.27%316.19M |
| Gains losses not affecting retained earnings | ---- | ---- | ---- | --0 | --0 | --0 | ---5K | ---39K | ---96K | ---96K |
| Total stockholders'equity | -40.55%25.37M | -53.00%21.62M | -45.40%30.04M | -43.54%37.09M | -43.54%37.09M | -15.95%42.67M | -23.01%46M | -14.93%55.02M | 0.29%65.68M | 0.29%65.68M |
| Total equity | -40.55%25.37M | -53.00%21.62M | -45.40%30.04M | -43.54%37.09M | -43.54%37.09M | -15.95%42.67M | -23.01%46M | -14.93%55.02M | 0.29%65.68M | 0.29%65.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data